{"prompt": "['Acupuncture for Chemotherapy-Induced Peripheral Neuropathy Among Cancer Patients', 'Wake Forest Baptist Comprehensive Cancer Center (WFBCCC)', 'CCCWFU # 97118', 'Appendix L: Patient Pre-Neuropathy Grading Instructions Card', 'The following information card will be handed to the patient at the end of treatment', 'assessment encounter by the nurse, technologist, or coordinator prior to clinical', 'assessment of neuropathy grade. End of treatment neuropathy grading will occur by', \"one of the neurologists on the study team who will be blinded to the patient's\", 'randomization and treatment allocation at the time of the assessment.', 'Thank you for participating in this study. A doctor will be coming', 'in to ask you some questions about your neuropathy. The doctor', 'will use this information to grade your neuropathy. This doctor will', 'not know whether you have been receiving acupuncture or not.', 'You may answer all questions. Please do not provide any', 'information about whether you have been receiving acupuncture', 'treatments or not until the doctor has completed his/her', 'assessment. Thank you.', 'Page 48 of 55']['Acupuncture for Chemotherapy-Induced Peripheral Neuropathy Among Cancer Patients', 'Wake Forest Baptist Comprehensive Cancer Center (WFBCCC)', 'CCCWFU # 97118', 'Appendix M: CTCAE Neuropathy Grading Form', 'OnCore PID:', 'Date Completed (mm/dd/yy):', '/', '/', 'PI: Nancy E. Avis, PhD', 'Study Number: CCCWFU 97118', 'Visit:', 'Baseline Date: (mm/dd/yy)', '/', '/', '12 week Date: (mm/dd/yy)', '/', '/', \"As the clinician grading this patient's neuropathy, you are blinded from the patient's\", 'treatment allocation. You may ask the patient questions to understand the grade of their', 'neuropathy but should not ask the patient to reveal their treatment arm.', \"Please select the appropriate grade of the patient's neuropathy based on your\", 'assessment today.', \"After you have selected the neuropathy grade, you may discuss the patient's prior\", 'treatment and prior randomization but do not change your selection.', 'CTCAE', 'Description of CTCAE', 'Question you may consider', 'Check the box that', 'Grade of', 'grade', 'asking:', 'corresponds to', 'neuropathy', 'neuropathy grade', 'Asymptomatic; clinical or', 'Do you have any numbness or', 'Grade 1', 'diagnostic observations', 'tingling in your hands, fingers,', 'only; intervention not', 'feet or toes?', 'indicated', 'Because of your neuropathy,', 'Moderate symptoms;', 'are you not able to clean your', 'Grade 2', 'home, cook meals, shop for', 'limiting instrumental ADL', 'groceries, or use your', 'telephone?', 'Because of your neuropathy,', 'Severe symptoms; limiting', 'are you not able to dress', 'Grade 3', 'self-care ADL; assistive', 'yourself, button your shirt or', 'device indicated', 'pants, bath or shower, cut your', 'food or eat?', 'Life-threatening', 'Grade 4', 'consequences; urgent', 'intervention indicated', 'Grade 5', 'Death', 'Page 49 of 55']['Acupuncture for Chemotherapy-Induced Peripheral Neuropathy Among Cancer Patients', 'Wake Forest Baptist Comprehensive Cancer Center (WFBCCC)', 'CCCWFU # 97118', 'Appendix N: Chemotherapy Form', 'OnCore PID:', 'Date Completed (mm/dd/yy):', '/', '/', 'PI:. Nancy E. Avis, PhD', 'Study Number: CCCWFU 97118', 'INSTRUCTIONS: To be completed at the post treatment visit. Use this form to summarize', 'regimen type and changes in regimen during the study', 'Total chemotherapy cycles completed:', '1', '2', '3', '4', '5', '6', 'Weeks completed (paclitaxel):', '1', '2', '3', '4', '5', '6', '7', '8', '9', '10', '11', '12', 'Was the chemotherapy regimen changed during treatment?', 'Yes', 'No', 'If yes, was it due to CIPN?', 'Yes', 'No', 'Partly (explain):', 'Start Date', 'Standard', 'Current', 'Current', 'Neurotoxic', 'Name', 'of regimen', 'neurotoxic', 'Dose', '(mm/dd/yy', 'cycle', 'week of P,', 'dose?', 'number', 'C, NP', ')', '(circle)', 'Doxorubicin/', 'AC-T', 'cyclophosphamide', '80 mg/m\u00b2', 'Yes No*', 'followed by weekly', 'paclitaxel (12 wk)', 'Docetaxel and', 'TC', '75 mg/m\u00b2', 'Yes No*', 'cyclophosphamide', 'TCH', 'Docetaxel/carboplatin/', '75 mg/m\u00b2', 'Yes No*', 'trastuzumab', 'TCHP', 'Docetaxel/carboplatin/', '75 mg/m\u00b2', 'Yes No*', 'trastuzumab +pertuzumab', 'TH', 'Paclitaxel (12 weeks) +', 'trastuzumab', '80 mg/m\u00b2', 'Yes No*', 'mFFX6', 'mFOLFOX6', 'O-85 mg', 'Yes No*', 'mg/m\u00b2', 'mFFX4', 'FOLFOX 4', 'O-85 mg', 'Yes No*', 'mg/m\u00b2', 'FFXI', 'FOLFOXIRI', 'O-85 mg', 'Yes No*', 'mg/m\u00b2', 'FFIX', 'FOLFIRINOX', 'O-85 mg', 'Yes No*', 'mg/m\u00b2', 'mFFIX', 'mFOLFORINOX', 'O-85 mg', 'Yes No*', 'mg/m\u00b2', 'T-50 mg/m\u00b2', 'FLOT', 'FLOT', 'O-85 mg', 'Yes No*', 'mg/m\u00b2', 'Nabpaclitaxel and', 'NP-125', 'NG', 'Yes No*', 'Gemcitabibe', 'mg/m\u00b2', 'CP', 'Carboplatin and Paclitaxel', 'C- AUC2', 'Yes No*', '(CROSS regimen)', 'P- - 50 mg/m\u00b2', 'Oth', 'Other (specify):', 'Yes No*', 'Page 50 of 55']\n\n###\n\n", "completion": "END"}